High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing’s tumors
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 7 (4) , 477-482
- https://doi.org/10.1007/s007760200083
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Allogeneic and autologous stem-cell transplantation in advanced Ewing tumorsAnnals of Oncology, 2000
- Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study GroupJournal of Clinical Oncology, 2000
- Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico RizzoliJournal of Clinical Oncology, 2000
- High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumorsBone Marrow Transplantation, 1999
- Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentBritish Journal of Cancer, 1999
- Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: The CESS 86 experienceMedical and Pediatric Oncology, 1999
- Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.Journal of Clinical Oncology, 1998
- High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumorsBone Marrow Transplantation, 1997
- High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcomaBone Marrow Transplantation, 1997
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.Journal of Clinical Oncology, 1993